Advanced Solid Tumor Clinical Trials
Advanced Solid Tumor clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for advanced Solid Tumor. Corterve aggregates actively recruiting Advanced Solid Tumor studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Advanced Solid Tumor studies
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor TherapiesNCT07213830PHASE1, PHASE2IpsenBoston, Massachusetts
- A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid TumoursNCT06833008PHASE1, PHASE2IpsenGrand Rapids, Michigan
- A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid TumoursNCT07213817PHASE1, PHASE2IpsenNew Haven, Connecticut
- A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid TumorsNCT07524348PHASE1Samsung Bioepis Co., Ltd.Scottsdale, Arizona
- Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerNCT05267626PHASE1, PHASE2Aulos Bioscience, Inc.Miami, Florida
- A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsNCT06792552PHASE1NextCure, Inc.Orlando, Florida
- Metarrestin (ML-246) in Subjects With Metastatic Solid TumorsNCT04222413PHASE1National Cancer Institute (NCI)Fairway, Kansas
- A Study of DS-1103a Combination Therapy in Participants With Advanced Solid TumorsNCT05765851PHASE1Daiichi SankyoSarasota, Florida
- A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.NCT07042100PHASE1Sun Pharma Advanced Research Company LimitedScottsdale, Arizona
- Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsNCT06915753PHASE1Tyra Biosciences, IncLos Angeles, California
- A Study of IDP-001 in Advanced or Metastatic Solid TumorsNCT07602842PHASE1, PHASE2InduPro, Inc.Los Angeles, California
- A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)NCT05067283PHASE1Merck Sharp & Dohme LLCTampa, Florida
Advanced Solid Tumor trials by state
Advanced Solid Tumor trials by metro
Frequently asked questions
- How do I find recruiting Advanced Solid Tumor clinical trials?
- Corterve aggregates actively recruiting Advanced Solid Tumor studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Advanced Solid Tumor clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Advanced Solid Tumor clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.